New Tools and Strategies for High Quality TMB Analysis by NGS

Get in Touch

Our Locations

New Tools and Strategies for High Quality TMB Analysis by NGS

Presented at AMP 2019

In this presentation, you will learn:

Q²Solutions' overall approach to supporting clinical trial testing
Analytical assay challenges considering panels vs. Whole Exome Sequencing (WES)
Lessons learned from Friends of Cancer Research regarding TMB harmonization
Importance of reference materials establishing assay validation, QC, and future needs in Immuno-oncology

Related Services & Solutions

Related Thought Leaders Insights

White Paper

Ensemble-based method for detecting differential expression in RNA datasets provides greater sensitivity and less biased p-values than existing methods

In examining two-group differential analysis, it is apparent that different statistical methods can yield very different results even given the same RNA-Seq input data. In particular, we have...

White Paper

Assay development, validation, and manufacturing with built-in quality controls

With more than 25 years of experience, Rules-Based Medicine, a Q² Solutions company develops, validates and manufactures its assays with integrity and commitment for the most reliable, reproducible...

Scientific Poster

Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs

By Chloe Ackaert, Jana Schockaert, Aurelie Mazy, Martijn Vlaming, and Sofie PattynPresented at the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024 Bispecifics...